CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA2D3 | Calcium channel, voltage-dependent, alpha 2/delta subunit 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAMLG | Calcium modulating ligand | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CATSPERD | Catsper channel auxiliary subunit delta | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CCDC109B | Coiled-coil domain containing 109B | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CCDC51 | Coiled-coil domain containing 51 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD200 | CD200 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD34 | CD34 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CECR6 | Cat eye syndrome chromosome region, candidate 6 | Predicted membrane proteins
| | | | | Group enriched |
CERS2 | Ceramide synthase 2 | Predicted membrane proteins
| | | | | Expressed in all |
CERS3 | Ceramide synthase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CERS4 | Ceramide synthase 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CFAP54 | Cilia and flagella associated 54 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNB1 | Cholinergic receptor, nicotinic, beta 1 (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CKLF-CMTM1 | CKLF-CMTM1 readthrough | Predicted membrane proteins
| | | | | Mixed |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN12 | Claudin 12 | Predicted membrane proteins
| | | | | Expressed in all |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLDND1 | Claudin domain containing 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CLEC7A | C-type lectin domain family 7, member A | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLN3 | Ceroid-lipofuscinosis, neuronal 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CLN6 | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CMTM1 | CKLF-like MARVEL transmembrane domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CMTM2 | CKLF-like MARVEL transmembrane domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CMTM3 | CKLF-like MARVEL transmembrane domain containing 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
CMTM8 | CKLF-like MARVEL transmembrane domain containing 8 | Predicted membrane proteins
| | | | | Mixed |
CMTR2 | Cap methyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | Predicted membrane proteins
| | | | | Expressed in all |
CNIH1 | Cornichon family AMPA receptor auxiliary protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
CNIH4 | Cornichon family AMPA receptor auxiliary protein 4 | Predicted membrane proteins
| | | | | Expressed in all |
COX20 | COX20 cytochrome C oxidase assembly factor | Predicted membrane proteins
| | | | | Mixed |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CPT1B | Carnitine palmitoyltransferase 1B (muscle) | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CPT1C | Carnitine palmitoyltransferase 1C | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSNK1A1 | Casein kinase 1, alpha 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CTAGE1 | Cutaneous T-cell lymphoma-associated antigen 1 | Predicted membrane proteins
| | | | | Tissue enriched |